Clinical Trial Update: The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial examining whether melatonin can reduce ischemia-reperfusion injury after acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• Myocardial Infarction

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Herlev Hospital | Conditions: Acute Myocardial Infarction, Ischemia-reperfusion Injury | Phase 2 | Status: COMPLETED